The Clinical Decision Support System Market Size is expected to be worth around US$ 16.2 Billion by 2034 from US$ 5.8 Billion in 2024.
TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier ...
The growing field of machine unlearning aims to make large language models forget harmful information without retraining them ...
What we encounter in LLMs is largely ourselves. A psychoanalytic AI take on transference, countertransference, and the ...
As AI accelerates across biopharma and other science-driven industries, organizations are encountering a critical bottleneck: ...
Analysis of the 191 samples shows that 55 percent of groundwater falls within low to no restriction categories for irrigation ...
The rapid increase in electric vehicle adoption in recent years has highlighted a crucial issue: the energy conversion efficiency of electric motors. In electric motors, iron loss or magnetic ...
An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...
The professionals who work in safety and quality management are accountable for human lives, consumer well-being, and brand ...
New capabilities across Qlik Answers, Discovery Agent, MCP Server, and new agents for prediction, automation, and analytics development help teams move from inquiry to action, with Discovery Agent ...
Artificial Intelligence (AI) has shown strong potential in supporting clinical decision-making through Clinical Decision Support Systems (CDSSs). However, ...
Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results